Impact of Lamivudine on the Risk of Liver-Related Death in 2,041 Hbsag- and HIV-Positive Individuals: Results from an Inter-Cohort Analysis
Author(s) -
Massimo Puoti,
Alessandro CozziLepri,
Giuseppe Paraninfo,
Claudio Arici,
Nina FriisMøller,
Jens Lundgren,
Bruno Ledergerber,
Martin Rickenbach,
Ignacio Suárez-Lozano,
Myriam Garrido,
François Dabis,
María Winnock,
Laura Milazzo,
Anne Gervais,
F. Raffi,
M. John Gill,
Juergen Rockstroh,
Nazifa Qurishi,
Cristina Mussini,
Antonella Castagna,
Andrea De Luca
Publication year - 2006
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.1177/135965350601100618
Subject(s) - lamivudine , hbsag , medicine , cohort , human immunodeficiency virus (hiv) , cohort study , virology , hepatitis b virus , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom